SII Investments’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,196
Closed -$242K 622
2017
Q3
$242K Sell
1,196
-303
-20% -$70.5K 0.01% 518
2017
Q2
$363K Buy
1,499
+134
+10% +$31.5K 0.02% 414
2017
Q1
$324K Buy
1,365
+235
+21% +$54.7K 0.02% 443
2016
Q4
$237K Buy
1,130
+200
+22% +$41.4K 0.02% 507
2016
Q3
$214K Sell
930
-263
-22% -$64.3K 0.02% 532
2016
Q2
$275K Buy
1,193
+422
+55% +$97.3K 0.02% 459
2016
Q1
$207K Sell
771
-1,328
-63% -$380K 0.02% 517
2015
Q4
$659K Sell
2,099
-107
-5% -$31.9K 0.08% 212
2015
Q3
$597K Buy
2,206
+1,425
+182% +$438K 0.07% 255
2015
Q2
$237K Buy
781
+37
+5% +$11K 0.03% 449
2015
Q1
$219K Buy
+744
New +$212K 0.03% 473

Other funds holding AGN

SII Investments's AGN Position: Q4 2017 in Review

SII Investments sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 1,196 shares — an estimated $242K sold.

SII Investments first reported a position in AGN in Q1 2015 and held it in 11 quarters. The position peaked at $659K in Q4 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • SII Investments reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • SII Investments sold 1,196 Allergan plc shares in Q4 2017, an estimated $242K.
  • SII Investments first reported a position in Allergan plc in Q1 2015 and held it in 11 quarters.
  • SII Investments's Allergan plc position peaked at $659K in Q4 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on SII Investments's 13F filing for Q4 2017, filed 9 Feb 2018.